Technology
Health
Medical

Avinger

$0.831
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0058 (-0.68%) Today
-$0.0149 (-1.76%) After Hours

Why Robinhood?

You can buy or sell Avinger and other stocks, options, ETFs, and crypto commission-free!

About

Avinger, Inc. Common Stock, also called Avinger, is a commercial-stage medical device company. Read More The firm designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Ocelot MVRX, Ocelot PIXL, Pantheris, Wildcat, Juicebox and Kittycat 2. It offers its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger was founded by John B. Simpson and Himanshu N. Patel on March 8, 2007 and is headquartered in Redwood City, CA.

Employees
75
Headquarters
Redwood City, California
Founded
2007
Market Cap
29.74M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.88M
High Today
$0.85
Low Today
$0.7918
Open Price
$0.819
Volume
881.93K
52 Week High
$2.44
52 Week Low
$0.18

Collections

Technology
Health
Medical
2015 IPO
US
North America

News

Seeking AlphaMar 7

Avinger files for $50M mixed shelf offering; shares down 2% after hours

Avinger (NASDAQ:AVGR) has filed a prospectus for a $50M mixed shelf offering. Shares are down 2% after hours....

4,010
Seeking AlphaMar 6

Avinger (AVGR) CEO Jeff Soinski on Q4 2018 Results - Earnings Call Transcript

Avinger (NASDAQ:AVGR) Q4 2018 Earnings Conference Call March 6, 2019 4:30 PM ET Company Participants Matt Kreps - IR Jeff Soinski - CEO Mark Weinswig - CFO Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Operator Greetings and welcome to Avinger’s 2018 Fourth Quarter and Full Year Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. [Operato...

1,753
Yahoo FinanceMar 6

Avinger Provides Fourth Quarter and Full Year 2018 Shareholder Update

Pantheris Fourth Quarter Revenue Increases 18% Over Prior Quarter REDWOOD CITY, Calif., March 06, 2019 (GLOBE NEWSWIRE) -- Avinger, Inc. (AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of patients with Peripheral Artery Disease (PAD), today reported results for the fourth quarter and full year ended December 31, 2018. Fourth Quarter and Recent Highlights Achieved revenue of $2.0 million for the ...

757

Earnings

-$10.40
-$6.93
-$3.47
$0.00
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 13, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.